Related Experiment Video
Updated: Feb 27, 2026

Affinity Purification of Influenza Virus Ribonucleoprotein Complexes from the Chromatin of Infected Cells
Published on: June 3, 2012
Reactive Oxygen Species-Regulating Polymersome as an Antiviral Agent against Influenza Virus
Hyun-Ouk Kim1, Minjoo Yeom2, Jihye Kim1
1Department of Chemical and Biomolecular Engineering, Yonsei University, Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.
Abstract:
Reactive oxygen species (ROS) produced during mitochondrial oxidative phosphorylation play an important role as signal messengers in the immune system and also regulate signal transduction. ROS production, initiated as a consequence of microbial invasion, if generated at high levels, induces activation of the MEK (mitogen-activated protein kinase kinase)/ERK (extracellular signal-regulated kinase) pathway to promote cell survival and proliferation. However, viruses hijack the host cells' pathways, causing biphasic activation of the MEK/ERK cascade. Thus, regulation of ROS leads to concomitant inhibition of virus replication. In the present study, poly(aniline-co-pyrrole) polymerized nanoregulators (PASomes) to regulate intracellular ROS levels are synthesized, exploiting their oxidizing-reducing characteristics. Poly(aniline-co-pyrrole) embedded within an amphiphilic methoxy polyethylene glycol-block-polyphenylalanine copolymer (mPEG-b-pPhe) are used. It is demonstrated that the PASomes are water soluble, biocompatible, and could control ROS levels successfully in vitro, inhibiting viral replication and cell death. Furthermore, the effects of homopolymerized nanoregulators (polypyrrole assembled with mPEG-b-pPhe or polyaniline assembled with mPEG-b-pPhe) are compared with those of the PASomes. Consequently, it is confirmed that the PASomes can regulate intracellular ROS levels successfully and suppress viral infection, thereby increasing the cell survival rate.
Insights
New nanoregulators (PASomes) control reactive oxygen species (ROS) to inhibit viral replication and cell death. This breakthrough offers a novel strategy for antiviral therapies by regulating ROS levels in host cells.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Immunology
Background:
- Reactive oxygen species (ROS) are crucial signaling molecules in immunity and signal transduction.
- High ROS levels can activate survival pathways (MEK/ERK) but viruses exploit this, leading to biphasic activation.
- Regulating ROS is a potential strategy to inhibit viral replication.
Purpose of the Study:
- To synthesize and characterize poly(aniline-co-pyrrole) polymerized nanoregulators (PASomes).
- To investigate the ability of PASomes to control intracellular ROS levels.
- To evaluate the efficacy of PASomes in inhibiting viral replication and protecting host cells.
Main Methods:
- Synthesis of PASomes using poly(aniline-co-pyrrole) embedded in mPEG-b-pPhe copolymer.
- Assessment of PASome water solubility and biocompatibility.
- In vitro evaluation of ROS regulation, viral replication inhibition, and cell survival.
Main Results:
- PASomes were successfully synthesized, exhibiting water solubility and biocompatibility.
- PASomes effectively controlled intracellular ROS levels in vitro.
- PASomes demonstrated significant inhibition of viral replication and reduced cell death.
Conclusions:
- PASomes represent a novel nanoregulator system for controlling intracellular ROS.
- PASomes show promise as an antiviral strategy by suppressing viral infection and enhancing cell survival.
- The study highlights the therapeutic potential of ROS-regulating nanomedicines.
More Related Videos
Related Concept Videos
Leaky Scanning
Radical Chain-Growth Polymerization: Overview
Oxidation of Phenols to Quinones
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

